316 related articles for article (PubMed ID: 27276677)
1. A novel CBL-Bflox/flox mouse model allows tissue-selective fully conditional CBL/CBL-B double-knockout: CD4-Cre mediated CBL/CBL-B deletion occurs in both T-cells and hematopoietic stem cells.
Goetz B; An W; Mohapatra B; Zutshi N; Iseka F; Storck MD; Meza J; Sheinin Y; Band V; Band H
Oncotarget; 2016 Aug; 7(32):51107-51123. PubMed ID: 27276677
[TBL] [Abstract][Full Text] [Related]
2. An essential role of CBL and CBL-B ubiquitin ligases in mammary stem cell maintenance.
Mohapatra B; Zutshi N; An W; Goetz B; Arya P; Bielecki TA; Mushtaq I; Storck MD; Meza JL; Band V; Band H
Development; 2017 Mar; 144(6):1072-1086. PubMed ID: 28100467
[TBL] [Abstract][Full Text] [Related]
3. VAV1-Cre mediated hematopoietic deletion of CBL and CBL-B leads to JMML-like aggressive early-neonatal myeloproliferative disease.
An W; Mohapatra BC; Zutshi N; Bielecki TA; Goez BT; Luan H; Iseka F; Mushtaq I; Storck MD; Band V; Band H
Oncotarget; 2016 Sep; 7(37):59006-59016. PubMed ID: 27449297
[TBL] [Abstract][Full Text] [Related]
4. Spontaneous tumor rejection by cbl-b-deficient CD8+ T cells.
Loeser S; Loser K; Bijker MS; Rangachari M; van der Burg SH; Wada T; Beissert S; Melief CJ; Penninger JM
J Exp Med; 2007 Apr; 204(4):879-91. PubMed ID: 17403934
[TBL] [Abstract][Full Text] [Related]
5. Rapidly fatal myeloproliferative disorders in mice with deletion of Casitas B-cell lymphoma (Cbl) and Cbl-b in hematopoietic stem cells.
Naramura M; Nandwani N; Gu H; Band V; Band H
Proc Natl Acad Sci U S A; 2010 Sep; 107(37):16274-9. PubMed ID: 20805496
[TBL] [Abstract][Full Text] [Related]
6. Visualizing the role of Cbl-b in control of islet-reactive CD4 T cells and susceptibility to type 1 diabetes.
Hoyne GF; Flening E; Yabas M; Teh C; Altin JA; Randall K; Thien CB; Langdon WY; Goodnow CC
J Immunol; 2011 Feb; 186(4):2024-32. PubMed ID: 21248249
[TBL] [Abstract][Full Text] [Related]
7. Cutting edge: deficiency in the E3 ubiquitin ligase Cbl-b results in a multifunctional defect in T cell TGF-beta sensitivity in vitro and in vivo.
Wohlfert EA; Gorelik L; Mittler R; Flavell RA; Clark RB
J Immunol; 2006 Feb; 176(3):1316-20. PubMed ID: 16424156
[TBL] [Abstract][Full Text] [Related]
8. Loss of Cbl and Cbl-b ubiquitin ligases abrogates hematopoietic stem cell quiescence and sensitizes leukemic disease to chemotherapy.
An W; Nadeau SA; Mohapatra BC; Feng D; Zutshi N; Storck MD; Arya P; Talmadge JE; Meza JL; Band V; Band H
Oncotarget; 2015 Apr; 6(12):10498-509. PubMed ID: 25871390
[TBL] [Abstract][Full Text] [Related]
9. T cell activation threshold regulated by E3 ubiquitin ligase Cbl-b determines fate of inducible regulatory T cells.
Qiao G; Zhao Y; Li Z; Tang PQ; Langdon WY; Yang T; Zhang J
J Immunol; 2013 Jul; 191(2):632-9. PubMed ID: 23749633
[TBL] [Abstract][Full Text] [Related]
10. CBL family E3 ubiquitin ligases control JAK2 ubiquitination and stability in hematopoietic stem cells and myeloid malignancies.
Lv K; Jiang J; Donaghy R; Riling CR; Cheng Y; Chandra V; Rozenova K; An W; Mohapatra BC; Goetz BT; Pillai V; Han X; Todd EA; Jeschke GR; Langdon WY; Kumar S; Hexner EO; Band H; Tong W
Genes Dev; 2017 May; 31(10):1007-1023. PubMed ID: 28611190
[TBL] [Abstract][Full Text] [Related]
11. T cell specific deletion of Casitas B lineage lymphoma-b reduces atherosclerosis, but increases plaque T cell infiltration and systemic T cell activation.
Vos WG; van Os BW; den Toom M; Beckers L; van Roomen CPAA; van Tiel CM; Mohapatra BC; Band H; Nitz K; Weber C; Atzler D; de Winther MPJ; Bosmans LA; Lutgens E; Seijkens TTP
Front Immunol; 2024; 15():1297893. PubMed ID: 38504977
[TBL] [Abstract][Full Text] [Related]
12. The E3 ubiquitin ligase Cbl-b regulates expansion but not functional activity of self-reactive CD4 T cells.
St Rose MC; Qui HZ; Bandyopadhyay S; Mihalyo MA; Hagymasi AT; Clark RB; Adler AJ
J Immunol; 2009 Oct; 183(8):4975-83. PubMed ID: 19801520
[TBL] [Abstract][Full Text] [Related]
13. Regulation of T cell development by c-Cbl: essential role of Lck.
Chiang YJ; Hodes RJ
Int Immunol; 2015 May; 27(5):245-51. PubMed ID: 25477210
[TBL] [Abstract][Full Text] [Related]
14. Redundancy in B cell developmental pathways: c-Cbl inactivation rescues early B cell development through a B cell linker protein-independent pathway.
Song H; Zhang J; Chiang YJ; Siraganian RP; Hodes RJ
J Immunol; 2007 Jan; 178(2):926-35. PubMed ID: 17202354
[TBL] [Abstract][Full Text] [Related]
15. Lineage-specific transgene expression in hematopoietic cells using a Cre-regulated retroviral vector.
Turner VM; Gardam S; Brink R
J Immunol Methods; 2010 Aug; 360(1-2):162-6. PubMed ID: 20600080
[TBL] [Abstract][Full Text] [Related]
16. Control of the B cell-intrinsic tolerance programs by ubiquitin ligases Cbl and Cbl-b.
Kitaura Y; Jang IK; Wang Y; Han YC; Inazu T; Cadera EJ; Schlissel M; Hardy RR; Gu H
Immunity; 2007 May; 26(5):567-78. PubMed ID: 17493844
[TBL] [Abstract][Full Text] [Related]
17. Cbl-b gene silencing in splenic T lymphocytes as a therapeutic strategy to target the prostate cancer RM-1 cell tumors in immune competent mice.
Shi ZD; Li XF; Hao L; Zhao Y; Wang YX; Dong BZ; Chen WH; Zhang ZG; Wang YM; Fu Q; Han CH; Li S
Eur Rev Med Pharmacol Sci; 2014; 18(24):3819-30. PubMed ID: 25555872
[TBL] [Abstract][Full Text] [Related]
18. Loss of Cbl-PI3K interaction enhances osteoclast survival due to p21-Ras mediated PI3K activation independent of Cbl-b.
Adapala NS; Barbe MF; Tsygankov AY; Lorenzo JA; Sanjay A
J Cell Biochem; 2014 Jul; 115(7):1277-89. PubMed ID: 24470255
[TBL] [Abstract][Full Text] [Related]
19. Establishment of the major compatibility complex-dependent development of CD4+ and CD8+ T cells by the Cbl family proteins.
Huang F; Kitaura Y; Jang I; Naramura M; Kole HH; Liu L; Qin H; Schlissel MS; Gu H
Immunity; 2006 Oct; 25(4):571-81. PubMed ID: 17045823
[TBL] [Abstract][Full Text] [Related]
20. Structural Determinants of the Gain-of-Function Phenotype of Human Leukemia-associated Mutant CBL Oncogene.
Nadeau SA; An W; Mohapatra BC; Mushtaq I; Bielecki TA; Luan H; Zutshi N; Ahmad G; Storck MD; Sanada M; Ogawa S; Band V; Band H
J Biol Chem; 2017 Mar; 292(9):3666-3682. PubMed ID: 28082680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
